Metabolic syndrome and the risk of preeclampsia

Bratislava Medical Journal

Volumn 110, Issue 7, 2009, Pages 401-403

  Drobny Dr, J ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Cardiovascular diseases; Hypertension; Metabolic syndrome; Preeclampsia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; METABOLIC SYNDROME X; PREECLAMPSIA; PREGNANCY; RISK FACTOR;

ADOLESCENT; ADULT; FEMALE; HUMANS; METABOLIC SYNDROME X; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 68649126537     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mazar RM, Srinivas SK, Sammel MD et al. Metabolic score as a novel approach to assessing preeclampsia risk. Amer J Obstet Gyne-col 2007; 197: 411.el-411.e5.
2. Kim YM, Romero R, Oh SY et al. Toll-like receptor 4: A potential link between,danger signals", the innate immune system and preec lampsia? Amer J Obstet Gynecol 2005; 193: 921-927.
3. Salahuddin S, Lee Y, Vadnais M et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Amer J Obstet Gynecol 2007; 197: 28.el-28.e6.
4. Hayashi M, Ohkura T, Inaba N. Elevation of serum macrophage colony-stimulating factor before the clinical manifestation of preeclampsia. Amer J Obstet Gynecol 2003; 189: 1359-1350.
5. Lam GK, Whitecar PW, Orton S et al. Differential expression of TcR/CD3 zeta as evidence for altered immunoregulation in preec-lamptic versus normotensive women. Amer J Obstet Gynecol 2003; 189: 843-847.
6. Hackmon R, Koifman A, Hyobo H et al. Reduced third-trimester levels of soluble human leukocyte antigen - G protein in severe preeclampsia. Amer J Obstet Gynecol 2007; 197: 255.el-255.e5.
7. Braekke K, Holthe MR, Harsem NK et al. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Amer J Obstet Gynecol 2005; 193: 227-233.
8. Shah T, Walsh SW. Activation of NF-·B and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Amer J Obstet Gynecol 2007; 196: 48.el-48.e8.
9. Wang X, Athayde N, Trudinger B. Egr-1 transcription activation exists in placental endothelium when vascular disease is present. BJOG 2006; 113: 683-687.
10. Hendler I, Blackwell SC, Mehta SH et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Amer J Obstet Gynecol 2005; 193: 979-983.
11. Zusterzeel PL, te Morsche RHM, Raijmakers MTM et al. N-acetyl-transferase phenotype and risk for preeclampsia. Amer J Obstet Gynecol 2005; 193: 797-902.
12. Haggerty CL, Ferrell RE, Hubel CA et al. Association between allelic variants in cytokine genes and preeclampsia. Is J Obstet Cynical 2005; 193: 209-215.
13. Ajne G, Alborg G, Wolff K et al. Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia. Amer J Obstet Gynecol 2005; 193:234-240.
14. Stoll M, Dudenhause JW. Pathophysiologie der Präeklampsie. Geburtsh Frauenheilk 2005; 65: 1086-1090.
15. Ray JG, Diamond P, Singh G et al. Brief overview of maternal of a triglycerides as a risk factor for pre-eclampsia. BJOG 2006; 113: 379-386
16. Getahun D, Ananth CV, Oyelese Y et al. Primary preeclampsia in the second pregnancy. Obstet Gynecol 2007; 110: 1319-1325.
17. Zahumensky J, Sottner O, Krcmar M, Brtnicka H, Dvorska M, Masopustova Z, Kolarik D, Driak D, Halaska M. Planned and un-planned pregnancy -- comparison of a female sexuality and the course of labor. J Matemal Fetal & Neonatal Med 2006; 19 (Suppl 1).